Nonalcoholic steatohepatitis (NASH) is becoming a common cause of liver cirrhosis requiring liver transplantation (LT). Cardiovascular complications related to metabolic syndrome and NASH recurrence in the transplanted liver may affect the outcome of LT in these patients. We compared the outcomes of
Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C
β Scribed by Arun J. Sanyal; Colin Banas; Carol Sargeant; Velimir A. Luketic; Richard K. Sterling; Richard T. Stravitz; Mitchell L. Shiffman; Douglas Heuman; Adrian Coterrell; Robert A. Fisher; Melissa J. Contos; Alan S. Mills
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 164 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We read with interest the article by Bhagat et al. 1 regarding outcomes of liver transplantation (LT) in patient with cirrhosis due to nonalcoholic steatohepatitis (NASH) versus patients with cirrhosis due to alcoholic liver disease. This retrospective study showed no statistical differences in post
Although steatosis is a common histological feature in chronic hepatitis C (CHC), nonalcoholic steatohepatitis (NASH) has not yet been clearly characterized in this context. The aim of this prospective study was to investigate the characteristics of patients with NASH and CHC. Biopsies were categori
## Abstract Sera obtained from 381 patients with chronic liver disease from four cities within the USSR were studied for HBV, HDV, and HCV markers of infection. AntiβHCV activity was detected in 41.2% of nonβA, nonβB cases. The etiological distribution of chronic hepatitis in Moscow and Dushanbe wa
## BACKGROUND. To determine whether interferon (IFN) therapy can reduce incidence of the development of cirrhosis and hepatocellular carcinoma equally in patients with chronic hepatitis C virus (HCV) who responded differently to therapy, a retrospective analysis of 250 patients treated with IFN wa
We investigated the presence of positive (genomic) and negative (replicative intermediate) hepatitis C virus RNA strands in liver, peripheral mononuclear cells and serum from patients with chronic hepatitis C using a selective and semiquantitative polymerase chain reaction procedure. Negative and po